GO:0042781 3'-tRNA processing endoribonuclease activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0042781 describes the endonucleolytic removal of extra 3' nucleotides from tRNA precursors, leaving a 3'-hydroxy group on the tRNA and a 5'-phosphoryl group on the trailer molecule.
• The reaction is catalysed by RNase Z / tRNAse Z enzymes, which are conserved from bacteria to humans and are essential for tRNA maturation.
• In human mitochondria, RNase Z (ELAC2) is required for the maturation of mitochondrial tRNAs and for mitochondrial ribosome assembly.
• Defects in 3'-tRNA processing endoribonuclease activity are linked to mitochondrial dysfunction, ribosomopathies and cancer.
• CRISPR knockout, point-mutation, knock-in and overexpression models are powerful tools to dissect the function of RNase Z enzymes in tRNA processing.
• EDITGENE provides end-to-end CRISPR services to study GO:0042781-related genes, from cell model generation to library screening and bioinformatics.
Description
The Gene Ontology term GO:0042781, 3'-tRNA processing endoribonuclease activity, defines a molecular function that is essential for the maturation of transfer RNAs (tRNAs) across all domains of life. This activity catalyses the endonucleolytic cleavage of tRNA precursors to remove extra 3' nucleotides, generating the mature 3' terminus of tRNAs with a 3'-hydroxy group and releasing a trailer molecule with a 5'-phosphoryl group. Without this precise processing step, tRNAs cannot function in translation, and defects in the responsible enzymes have been linked to severe cellular and organismal phenotypes. Researchers studying RNA metabolism, mitochondrial biology and translation therefore need robust tools to investigate this activity. The enzyme responsible, often called RNase Z or tRNAse Z, is conserved from bacteria to humans and is encoded by genes such as ELAC2 in humans. In mitochondria, RNase Z is required for the maturation of mitochondrial tRNAs and for the assembly of the mitochondrial ribosome, highlighting its importance beyond the cytosol. This article provides a comprehensive overview of the mechanism, key genes, disease relevance and research methods for GO:0042781, with a focus on how CRISPR-based models can accelerate discovery.
3'-tRNA processing endoribonuclease activity At A Glance
| GO ID | GO:0042781 |
|---|---|
| GO term | 3'-tRNA processing endoribonuclease activity |
| Ontology | molecular_function |
| Synonym | RNase Z activity; tRNA 3' endonuclease activity; 3' tRNase activity; ribonuclease Z activity |
| Major function | Endonucleolytic cleavage of tRNA precursors to remove 3' trailer sequences, generating mature tRNA 3' termini |
| Catalytic residues | RNase Z enzymes typically use a histidine motif and a metal ion for catalysis |
| Subcellular location | Nucleus, mitochondria, and chloroplasts in eukaryotes; cytoplasm in bacteria |
| Representative genes | ELAC2 (human), Trz1 (yeast), RNase Z (bacteria) |
What Is GO:0042781?
3'-tRNA processing endoribonuclease activity (GO:0042781) is the catalytic activity that cleaves tRNA precursor molecules endonucleolytically to remove extra 3' nucleotides, thereby generating the mature 3' terminus of tRNAs. The cleavage leaves a 3'-hydroxy group at the tRNA terminus and a 5'-phosphoryl group at the trailer molecule. This activity is also known as RNase Z activity, tRNA 3' endonuclease activity, or 3' tRNase activity.
Why Is 3'-tRNA processing endoribonuclease activity Important in Cell Biology?
3'-tRNA processing endoribonuclease activity is essential for the production of functional tRNAs, which are required for protein synthesis in all cells. In eukaryotes, this activity is also critical for mitochondrial tRNA maturation and mitochondrial ribosome assembly, and its dysfunction has been associated with mitochondrial diseases, ribosomopathies and cancer. Understanding this activity at the molecular level can inform therapeutic strategies for diseases caused by defects in tRNA processing.
• Required for the maturation of all tRNAs, which are essential for translation.
• Defects in RNase Z cause accumulation of unprocessed tRNA precursors, leading to cellular stress.
• Mitochondrial RNase Z (ELAC2) is necessary for mitochondrial tRNA maturation and ribosome assembly.
• Mutations in ELAC2 are associated with mitochondrial dysfunction and have been linked to diseases such as hypertrophic cardiomyopathy and neurodevelopmental disorders.
• RNase Z activity is conserved across bacteria, archaea and eukaryotes, making it a target for antibiotic development.
• In Tetrahymena, Piwi-bound tRNA 3' fragments regulate Xrn2-dependent RNA processing, linking this activity to non-coding RNA pathways.
• Chloroplast tRNA processing also relies on 3' endonucleolytic activity, important for plant development.
• The activity is a potential biomarker for mitochondrial diseases and cancer.
• CRISPR screens can identify synthetic lethal interactions with RNase Z, revealing new drug targets.
• Studying this activity helps understand the evolution of RNA processing mechanisms.
What Happens During 3'-tRNA processing endoribonuclease activity?
Recognition of tRNA precursor substrates
In simple terms: The enzyme first finds and binds to the immature tRNA molecule.
RNase Z enzymes recognize tRNA precursors by their characteristic cloverleaf structure and the presence of a 3' trailer sequence. In bacteria, the enzyme binds to the elbow region of the tRNA and positions the scissile phosphate for cleavage. In eukaryotes, additional factors may assist in substrate recognition, especially in mitochondria where tRNA precursors have distinct features.
Endonucleolytic cleavage
In simple terms: The enzyme cuts the RNA chain at a specific point near the 3' end.
The catalytic mechanism involves a metal ion (usually Mg2+) coordinated by conserved histidine residues, which activates a water molecule for nucleophilic attack on the phosphodiester bond. This cleavage removes the 3' trailer and leaves a 3'-hydroxy group on the tRNA and a 5'-phosphoryl group on the trailer. The reaction is highly precise, ensuring the correct 3' terminus for tRNA function.
Release of mature tRNA and trailer
In simple terms: After cutting, the mature tRNA and the discarded trailer are released.
Following cleavage, the mature tRNA is released and can participate in translation, while the trailer molecule is further degraded by exonucleases. In Tetrahymena, the trailer fragments can be bound by Piwi proteins and regulate Xrn2 activity in the nucleus, indicating that these products are not merely waste.
Quality control and proofreading
In simple terms: The enzyme ensures that only correctly folded tRNAs are processed.
RNase Z enzymes have proofreading mechanisms to avoid cleaving non-tRNA substrates. Structural studies of human ELAC2 reveal a narrow active site that accommodates the tRNA acceptor stem, ensuring specificity. Mutations in the active site can lead to unprocessed tRNA accumulation and cellular toxicity.
Key Genes Involved in GO:0042781 3'-tRNA processing endoribonuclease activity
The following genes encode enzymes or associated factors that carry out or regulate 3'-tRNA processing endoribonuclease activity.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ELAC2 | Human RNase Z; catalyses 3' endonucleolytic cleavage of mitochondrial and nuclear tRNA precursors | Mutations linked to mitochondrial disease and cancer; target for CRISPR knockout studies |
| TRZ1 | Yeast RNase Z; essential for tRNA 3' processing | Model for studying conserved mechanism and substrate specificity |
| RNase Z (bacterial) | Bacterial tRNA 3' endonuclease | Antibiotic target; structural studies |
| TRMT10A | tRNA methyltransferase; may influence processing | Associated with tRNA modification and processing defects |
| XRN2 | Exonuclease involved in degradation of tRNA trailers | Interacts with Piwi-bound tRNA fragments in Tetrahymena |
| Piwi (Tetrahymena) | Binds mature tRNA 3' fragments and activates Xrn2 | Links tRNA processing to nuclear RNA surveillance |
| ELAC1 | Human RNase Z homolog; less characterized | Potential backup or tissue-specific function |
| MTPAP | Mitochondrial poly(A) polymerase; adds poly(A) tails to mitochondrial tRNAs | Affects tRNA maturation and stability |
| PNPT1 | Mitochondrial exoribonuclease; degrades tRNA trailers | Mutations cause mitochondrial disease |
| TRIT1 | tRNA isopentenyltransferase; modifies tRNAs | May influence processing efficiency |
| NSUN2 | tRNA methyltransferase; modifies tRNAs | Linked to tRNA stability and processing |
| DICER1 | Processes tRNA-derived fragments | Cross-talk with tRNA processing pathways |
| AGO2 | Binds tRNA fragments | Potential role in tRNA fragment function |
| TRMT6/TRMT61A | tRNA methyltransferases | Modify tRNA and affect processing |
| PUS1 | Pseudouridine synthase; modifies tRNAs | Defects cause mitochondrial myopathy |
| TRMU | tRNA 2-thiolation enzyme | Mutations cause mitochondrial disease |
| GTPBP3 | tRNA modification enzyme | Mitochondrial tRNA modification and processing |
| MTO1 | tRNA modification enzyme | Mitochondrial tRNA modification and processing |
How Is 3'-tRNA processing endoribonuclease activity Regulated?
The activity of 3'-tRNA processing endoribonuclease is regulated at multiple levels. In mitochondria, the expression of ELAC2 is coordinated with other tRNA processing factors to ensure efficient maturation. The activity can be modulated by post-translational modifications, although specific modifications are not fully characterized. In Tetrahymena, the interaction between Piwi-bound tRNA fragments and Xrn2 provides a regulatory feedback loop that links tRNA processing to nuclear RNA surveillance. Additionally, the availability of substrate tRNAs and the presence of modifying enzymes can influence the efficiency of cleavage.
3'-tRNA processing endoribonuclease activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ELAC2 | Mitochondrial disease, hypertrophic cardiomyopathy, neurodevelopmental delay | CRISPR knockout in HEK293T or patient fibroblasts; point mutations to mimic patient variants |
| ELAC2 | Prostate cancer susceptibility | Knockout in prostate cancer cell lines; overexpression in normal prostate cells |
| PNPT1 | Mitochondrial disease with tRNA processing defects | Knockout in HeLa cells; rescue with wild-type or mutant PNPT1 |
| MTPAP | Spastic ataxia, mitochondrial tRNA polyadenylation defects | Knockout in neurons; knock-in of patient mutations |
| TRMT10A | Microcephaly, short stature, tRNA modification defects | CRISPR knockout in iPSCs; differentiation to neurons |
Mitochondrial diseases
Mutations in ELAC2, the human RNase Z, cause defects in mitochondrial tRNA processing, leading to impaired mitochondrial translation and respiratory chain deficiency. Patients present with a range of symptoms including hypertrophic cardiomyopathy, lactic acidosis, and neurodevelopmental delay. Studies in patient cells and animal models have shown that unprocessed tRNA precursors accumulate and trigger mitochondrial stress responses.
Cancer
ELAC2 has been implicated in prostate cancer susceptibility, and altered expression of tRNA processing enzymes is observed in various cancers. Dysregulated tRNA processing can promote tumorigenesis by affecting translation and cellular stress responses. Targeting RNase Z activity may offer therapeutic opportunities in cancers with elevated tRNA demand.
Ribosomopathies and neurodevelopmental disorders
Defects in tRNA processing can lead to ribosome assembly defects and are associated with neurodevelopmental disorders. For example, mutations in ELAC2 cause a ribosomopathy-like phenotype with mitochondrial dysfunction. Understanding the link between GO:0042781 and ribosome biogenesis may reveal new therapeutic targets.
From 3'-tRNA processing endoribonuclease activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does ELAC2 knockout affect mitochondrial tRNA maturation? | CRISPR knockout in HEK293T or HeLa cells followed by RNA-seq and Northern blot |
| What is the effect of a patient-specific ELAC2 point mutation? | CRISPR point mutation knock-in in patient fibroblasts or iPSCs |
| Can wild-type ELAC2 rescue the knockout phenotype? | Knock-in of tagged ELAC2 (e.g., FLAG) for rescue and localization studies |
| Does overexpression of ELAC2 enhance tRNA processing? | Overexpression of ELAC2 in cell lines with low endogenous levels |
| What are the synthetic lethal partners of ELAC2? | CRISPR library screening in ELAC2-knockout cells |
| How does ELAC2 interact with other tRNA processing factors? | Proteomics (BioID, AP-MS) using tagged ELAC2 knock-in |
How to Study the 3'-tRNA processing endoribonuclease activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global transcript levels, including tRNA precursors | Detect accumulation of unprocessed tRNAs in knockout cells |
| tRNA-seq | Mature tRNA abundance and modifications | Quantify changes in tRNA pools after RNase Z perturbation |
| Northern blot | Specific tRNA precursor and mature tRNA levels | Validate processing defects |
| In vitro cleavage assay | Endonuclease activity of purified RNase Z | Test catalytic mutants and inhibitors |
| AP-MS | Protein-protein interactions | Identify components of the tRNA processing complex |
| BioID | Proximity-dependent biotinylation | Map interactome of RNase Z in living cells |
| Cryo-EM | 3D structure of RNase Z-tRNA complex | Understand substrate recognition and catalysis |
| CRISPR screen | Genetic dependencies and synthetic lethality | Find genes that interact with ELAC2 |
RNA sequencing and tRNA profiling
RNA-seq and specialized tRNA-seq methods can quantify the accumulation of unprocessed tRNA precursors upon knockout or knockdown of RNase Z. Northern blotting with probes specific to tRNA 3' trailers can directly detect processing intermediates. These methods are essential to confirm the functional impact of CRISPR edits.
Proteomics and interactomics
Affinity purification coupled to mass spectrometry (AP-MS) or proximity labeling (BioID) using tagged RNase Z can identify interacting proteins and substrates. This helps define the composition of the tRNA processing machinery and its regulation.
Structural biology
Cryo-EM and X-ray crystallography have revealed the architecture of human ELAC2 and bacterial RNase Z, providing insights into substrate recognition and catalysis. These structures guide mutagenesis studies to test the role of specific residues.
Functional assays for endonuclease activity
In vitro cleavage assays using radiolabeled or fluorescently labeled tRNA precursors can measure the endonucleolytic activity of purified RNase Z. These assays are used to validate the effects of point mutations and to screen for inhibitors.
How CRISPR Can Be Used to Study GO:0042781 3'-tRNA processing endoribonuclease activity
Knockout
CRISPR knockout of ELAC2 or other RNase Z genes in cell lines such as HEK293T or HeLa results in the accumulation of unprocessed tRNA precursors and mitochondrial dysfunction. These models are valuable for studying the consequences of loss of 3'-tRNA processing endoribonuclease activity and for identifying compensatory pathways.
Point Mutation
CRISPR point mutation knock-in can introduce patient-specific mutations in ELAC2, such as those found in mitochondrial disease, to study their effects on enzyme activity and tRNA processing. This approach allows precise modeling of disease-associated variants in isogenic backgrounds.
Knock-in
Knock-in of tagged ELAC2 (e.g., FLAG, HA, or GFP) enables localization, interaction and rescue studies. Tagged knock-in cell lines can be used for AP-MS or imaging to determine the subcellular localization of RNase Z.
Overexpression
Overexpression of wild-type or mutant ELAC2 in cell lines can enhance or disrupt tRNA processing, respectively. This is useful to test gain-of-function effects and to produce large amounts of enzyme for biochemical assays.
How EDITGENE Supports 3'-tRNA processing endoribonuclease activity Research
Researchers studying 3'-tRNA processing endoribonuclease activity-related genes often need to determine whether a candidate gene is causally involved in tRNA maturation, mitochondrial function, or disease. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell models, enabling functional validation and mechanistic studies.
Contact EDITGENE today to design your custom CRISPR model for 3'-tRNA processing endoribonuclease activity research.
Frequently Asked Questions About 3'-tRNA processing endoribonuclease activity
What is 3'-tRNA processing endoribonuclease activity?
It is the enzymatic activity that removes extra 3' nucleotides from tRNA precursors, generating mature tRNA 3' ends. This activity is classified as GO:0042781.
What genes are involved in 3'-tRNA processing endoribonuclease activity?
Key genes include ELAC2 (human RNase Z), TRZ1 (yeast), and bacterial RNase Z. Other factors such as PNPT1 and MTPAP assist in tRNA maturation.
Which enzyme carries out 3'-tRNA processing endoribonuclease activity?
The enzyme is commonly known as RNase Z or tRNAse Z, encoded by ELAC2 in humans.
What diseases are associated with defects in 3'-tRNA processing endoribonuclease activity?
Mutations in ELAC2 cause mitochondrial diseases, hypertrophic cardiomyopathy, and neurodevelopmental disorders. Altered activity has also been linked to cancer.
How can I study 3'-tRNA processing endoribonuclease activity in the lab?
Common methods include RNA-seq, tRNA-seq, Northern blot, in vitro cleavage assays, and CRISPR knockout models.
What is the role of ELAC2 in mitochondria?
ELAC2 is the mitochondrial RNase Z that processes mitochondrial tRNA precursors, essential for mitochondrial translation and ribosome assembly.
Can CRISPR be used to model RNase Z deficiency?
Yes, CRISPR knockout of ELAC2 in cell lines recapitulates tRNA processing defects and mitochondrial dysfunction.
What are the synonyms for GO:0042781?
Synonyms include RNase Z activity, tRNA 3' endonuclease activity, 3' tRNase activity, and ribonuclease Z activity.
How does 3'-tRNA processing endoribonuclease activity relate to translation?
Mature tRNAs are essential for translation; without 3' processing, tRNAs cannot function, leading to impaired protein synthesis.
What model systems are used to study 3'-tRNA processing endoribonuclease activity?
Model systems include human cell lines (HEK293T, HeLa), yeast, bacteria, and Tetrahymena, each offering unique insights.
Conclusion
3'-tRNA processing endoribonuclease activity (GO:0042781) is a fundamental molecular function required for tRNA maturation and translation. Its dysregulation is linked to mitochondrial diseases, cancer, and neurodevelopmental disorders. Advances in CRISPR technology enable precise modeling of this activity, and EDITGENE offers comprehensive services to support such research. Understanding the mechanism and regulation of RNase Z enzymes will continue to reveal new therapeutic opportunities.
References
- 1. Meynier V et al.. 2024. Structural basis for human mitochondrial tRNA maturation.. Nat Commun 15(1):4683 PMID: 38824131
- 2. Chen JY et al.. 1988. Biosynthesis of tRNA in yeast mitochondria. An endonuclease is responsible for the 3'-processing of tRNA precursors.. J Biol Chem 263(27):13677-82 PMID: 2843529
- 3. Couvillion MT et al.. 2012. A Tetrahymena Piwi bound to mature tRNA 3' fragments activates the exonuclease Xrn2 for RNA processing in the nucleus.. Mol Cell 48(4):509-20 PMID: 23084833
- 4. Rackham O et al.. 2016. Hierarchical RNA Processing Is Required for Mitochondrial Ribosome Assembly.. Cell Rep 16(7):1874-90 PMID: 27498866
- 5. Siira SJ et al.. 2018. Concerted regulation of mitochondrial and nuclear non-coding RNAs by a dual-targeted RNase Z.. EMBO Rep 19(10) PMID: 30126926
- 6. Greenberg BM et al.. 1984. Accurate processing and pseudouridylation of chloroplast transfer RNA in a chloroplast transcription system.. Plant Mol Biol 3(2):97-109 PMID: 24310305
- 7. Randau L et al.. 2005. The heteromeric Nanoarchaeum equitans splicing endonuclease cleaves noncanonical bulge-helix-bulge motifs of joined tRNA halves.. Proc Natl Acad Sci U S A 102(50):17934-9 PMID: 16330750
